Campbell/Spillane Substance Use Research - Interview with Charles Gorodetzky

Abstract

Charles W. Gorodetzky, M.D., Ph.D., conducted clinical research in drug metabolism and kinetics at the Lexington Narcotics Hospital for more than twenty years. Arriving at Lexington in 1963 after graduating from medical school, Gorodetzky then pursued a Ph.D. in pharmacology at the University of Kentucky, with William (Bill) Martin serving as his dissertation advisor. In his interview, Gorodetzky reflects on the intellectual climate at Lexington, the wide range of research conducted, the ethical questions involved, and the Lexington Narcotics Hospital within the nexus of government, industry, and academia. Among his many contributions was the development of innovative experimental designs for clinical research. As deputy director and then scientific director of the Addiction Research Center, he oversaw the conclusion of the research program at Lexington during the early 1980s. He served on the FDA’s Drug Abuse Advisory Committee from 1978-83. Dr. Gorodetzky then worked as an external consultant for the National Institute on Drug Abuse (NIDA) and took a series of positions in industry, where he continued his research in substance abuse treatment and smoking cessation. Dr. Gorodetzky is now retired. Source: Transcript